The performance of multinational corporations in emerging markets is increasingly challenged by macroeconomic, market-based, and competitive factors. MNCs must focus more on improving competitiveness with rapid productivity gains. To succeed, many will need to undertake a fundamental transformation of their local operations—one country at a time. > More
Despite general challenges to productivity in biopharma R&D, a few companies continue to excel. The key is their superior organizational effectiveness, which enhances cooperative behavior among R&D staff.